Lisdexamfetamine Dimesylate 00054-0375-25
- Manufacturer
- Hikma Pharmaceuticals Usa Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- August 25, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA202827
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 70 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
00054-0375-25Selected100 CAPSULE in 1 BOTTLE (0054-0375-25)